Internal Medicine, Hematology & Oncology · Peoria, IL
NPI
1215450119
Since 2017
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8940 N Wood Sage Rd
Peoria, IL, 61615
Phone (309) 243-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
96,294 services
Medicare patients, 2024
602
Average age 75
Drug cost, 2024
$1.5M
789 prescriptions
Company payments, 2025
$113
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vatsala Katiyar was code J1439 (injection, ferric carboxymaltose, 1 mg), 12,000 times for 15 patients. In total Vatsala Katiyar billed 96,294 services in 176 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 12,000 | 15 | $0.87 | $10K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 10,200 | 17 | $0.27 | $2,762 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 8,000 | 20 | $45.28 | $362K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 5,490 | 59 | $0.11 | $601 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2,675 | 11 | $2.36 | $6,313 |
| J0897 Injection, denosumab, 1 mg | Office | 1,800 | 17 | $21.20 | $38K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 686 | 46 | $0.09 | $60.96 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 540 | 12 | $6.07 | $3,279 |
| 85025 Blood Count | Office | 484 | 175 | $7.61 | $3,683 |
| 80053 Clinical Chemistry | Office | 452 | 164 | $10.35 | $4,678 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 380 | 29 | $0.63 | $241 |
| 36415 Venipuncture Blood Collection | Office | 322 | 154 | $8.65 | $2,785 |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 294 | 27 | $0.39 | $115 |
| 99214 Office E&M - Established | Office | 277 | 134 | $94.74 | $26K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 256 | 25 | $0.07 | $17.62 |
By year: 2023 $26K for 1,279 services; 2024 $1.6M for 96,294 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 484 | 175 | $7.61 | $3,683 |
| 80053 Clinical Chemistry | 452 | 164 | $10.35 | $4,678 |
| 36415 Venipuncture Blood Collection | 322 | 154 | $8.65 | $2,785 |
| 83550 Clinical Chemistry | 80 | 58 | $8.57 | $686 |
| 82728 Clinical Chemistry | 80 | 58 | $13.36 | $1,069 |
| 83540 Clinical Chemistry | 80 | 58 | $6.34 | $507 |
| 83735 Clinical Chemistry | 77 | 29 | $6.57 | $506 |
| 83521 Immunoassay | 74 | 23 | $16.93 | $1,252 |
| 83615 Clinical Chemistry | 64 | 46 | $5.92 | $379 |
| 84443 Clinical Chemistry | 57 | 20 | $16.46 | $938 |
Medicare prescription drug claims, 2024
In 2024, the drug Vatsala Katiyar prescribed most often to Medicare patients was Acyclovir, with 52 prescriptions and refills. In total Vatsala Katiyar wrote 789 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 52 | 60 | Under 11 | $731 |
| Dexamethasone Generic | 49 | 50 | 16 | $352 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 47 | 49 | 11 | $212 |
| Prochlorperazine Maleate Generic | 41 | 41 | 25 | $435 |
| Eliquis Apixaban | 40 | 46 | Under 11 | $27K |
| Prednisone Generic | 36 | 38 | Under 11 | $186 |
| Ondansetron Hcl Generic | 31 | 31 | 24 | $218 |
| Anastrozole Generic | 31 | 73 | Under 11 | $539 |
| Abiraterone Acetate Generic | 26 | 26 | Under 11 | $11K |
| Levothyroxine Sodium Generic | 25 | 53 | Under 11 | $224 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 24 | 24 | 12 | $515 |
| Olanzapine Generic | 22 | 23 | Under 11 | $115 |
| Fulphila Pegfilgrastim-Jmdb | 20 | 20 | Under 11 | $39K |
| Lenalidomide Generic | 20 | 20 | Under 11 | $353K |
| Loperamide Loperamide Hcl | 16 | 16 | Under 11 | $120 |
Brand drugs: 162 claims; generic drugs: 627 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vatsala Katiyar $113 ($113 in general payments such as food, travel and fees) from 3 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $55.46.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.